Get the Stockscreener App
13.64
9.65%
1.20
Pre-market:
13.78
0.14
+1.03%
10 X Genomics Inc stock is traded at $13.64, with a volume of 2.61M.
It is up +9.65% in the last 24 hours and up +16.68% over the past month.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
See More
Previous Close:
$12.44
Open:
$12.56
24h Volume:
2.61M
Relative Volume:
0.96
Market Cap:
$1.56B
Revenue:
$631.73M
Net Income/Loss:
$-239.78M
P/E Ratio:
-6.7525
EPS:
-2.02
Net Cash Flow:
$-33.45M
1W Performance:
-0.94%
1M Performance:
+16.68%
6M Performance:
+64.93%
1Y Performance:
-14.91%
1-Day Range:
$12.44
$13.85
1-Week Range:
$12.34
$13.86
52-Week Range:
$6.78
$18.21
10 X Genomics Inc Stock (TXG) Company Profile
Name
10 X Genomics Inc
Sector
Industry
Phone
(925) 401-7300
Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
13.64 | 1.55B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
291.20 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.85 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.00 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.58 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.85 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | Piper Sandler | Neutral |
| Feb-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-22-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-18-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-10-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-25-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-03-24 | Resumed | Jefferies | Hold |
| May-01-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-10-23 | Initiated | Barclays | Overweight |
| Mar-31-23 | Initiated | Stephens | Overweight |
| Feb-02-23 | Initiated | UBS | Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Aug-18-22 | Downgrade | Goldman | Neutral → Sell |
| Jul-25-22 | Initiated | Canaccord Genuity | Buy |
| Jul-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-15-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-14-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-15-21 | Initiated | William Blair | Outperform |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Overweight |
| Jul-10-20 | Initiated | Stifel | Buy |
| Mar-05-20 | Initiated | Guggenheim | Buy |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-07-19 | Initiated | BofA/Merrill | Buy |
| Oct-07-19 | Initiated | Cowen | Outperform |
| Oct-07-19 | Initiated | JP Morgan | Overweight |
| Sep-24-19 | Initiated | Evercore ISI | Outperform |
View All
10 X Genomics Inc Stock (TXG) Latest News
Is 10x Genomics Inc. stock a safe investment in uncertain marketsStop Loss & Daily Entry Point Trade Alerts - newser.com
10x Genomics (NASDAQ:TXG) Shares Up 10%What's Next? - MarketBeat
Sumitomo Mitsui Trust Group, Inc. Adjusts Holdings in 10x Genomi - GuruFocus
Advanced analytics toolkit walkthrough for 10x Genomics Inc.Portfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Ethic Inc. Invests $289,000 in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research - Lelezard
ARK Investment Acquires New Shares in 10x Genomics (TXG) - GuruFocus
10x Genomics Launches New Chromium Flex for Single-Cell Research - Contract Pharma
10x Genomics (NASDAQ: TXG) launches Chromium Flex enabling 384-sample plate multiplexing - Stock Titan
Why 10x Genomics Inc. stock appeals to dividend seekers2025 Historical Comparison & AI Forecast Swing Trade Picks - fcp.pa.gov.br
Is 10x Genomics Inc. (1KJ) stock undervalued historicallyEarnings Risk Summary & Short-Term Trading Alerts - newser.com
Canaccord Genuity Keeps Their Buy Rating on 10x Genomics (TXG) - The Globe and Mail
IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases 184,757 Shares of 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock ready for a breakoutNew Guidance & Smart Allocation Stock Reports - newser.com
How geopolitical tensions affect 10x Genomics Inc. stockDividend Hike & Risk Controlled Daily Trade Plans - newser.com
What’s the recovery path for long term holders of 10x Genomics Inc.2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
Is 10x Genomics Inc. stock dividend yield sustainable2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
How 10x Genomics Inc. stock trades before earningsCPI Data & Expert Curated Trade Setups - fcp.pa.gov.br
Sumitomo Mitsui Trust Group Inc. Acquires 654,597 Shares of 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Given Average Rating of "Hold" by Brokerages - MarketBeat
Ranking 10x Genomics Inc. among high performing stocks via toolsStop Loss & Fast Momentum Entry Tips - newser.com
Is 10x Genomics Inc. stock entering bullish territoryJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Is 10x Genomics Inc. (1KJ) stock nearing a technical breakoutWeekly Investment Recap & Smart Swing Trading Alerts - newser.com
Will 10x Genomics’ (TXG) AI Partnership Shift Its Long-Term Competitive Edge in Genomics? - Yahoo Finance
What momentum shifts mean for 10x Genomics Inc.July 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Globe and Mail
Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Motley Fool
Cookson Peirce & Co. Inc. Takes Position in 10x Genomics $TXG - MarketBeat
SPT Labtech and 10x Genomics Partner To Automate Single Cell Workflows - Technology Networks
10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents - IPWatchdog.com
Why 10x Genomics Inc. (1KJ) stock trades below fair valueQuarterly Market Summary & Verified Chart Pattern Signals - newser.com
Will 10x Genomics Inc. stock gain from lower inflationEarnings Miss & Fast Gain Stock Trading Tips - newser.com
10x Genomics Hits Illumina With 2 Gene Tech Patent Suits - Law360
10x sues rival Illumina over gene-sequencing patents - Reuters
10x Genomics (TXG) Takes Legal Action Against Illumina Over Pate - GuruFocus
Illumina faces patent lawsuits from 10x Genomics over gene sequencing tech - Seeking Alpha
Illumina Hit with 10X Genomics Patent Suits Over Sequencing Tech - Bloomberg Law News
10x Genomics, Inc. (TXG) Stock Analysis: A 13.07% Potential Upside In Health Information Services - DirectorsTalk Interviews
10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance
10x Genomics partners with Anthropic to make biology research more accessible - Investing.com Canada
10X Genomics (TXG) Partners with Anthropic to Simplify Scientifi - GuruFocus
Can 10x Genomics Inc. stock deliver surprise earnings beatWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
10X Genomics to integrate analysis tools into Anthropic's Claude for Life Sciences - Seeking Alpha
10x Genomics partners with Anthropic to make biology research more accessible By Investing.com - Investing.com South Africa
10x Genomics Partners With Anthropic To Bring AI Tools For Researchers - Stocktwits
10 X Genomics Inc Stock (TXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
10 X Genomics Inc Stock (TXG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Taich Adam | Chief Financial Officer |
Aug 22 '25 |
Sale |
13.79 |
22,315 |
307,657 |
309,273 |
| Hindson Benjamin J. | See Remarks |
Aug 22 '25 |
Sale |
13.79 |
7,486 |
103,209 |
440,888 |
2.38%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):